Review: could Erbitux cause White Blood Cell Count Decreased?


Summary

White blood cell count decreased is found among people who take Erbitux, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Cisplatin, and have Non-small cell lung cancer . We study 8,126 people who have side effects while taking Erbitux from FDA and social media. Among them, 201 have White blood cell count decreased. Find out below who they are, when they have White blood cell count decreased and more.

You are not alone

Join a support group for people who take Erbitux and have White blood cell count decreased >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Erbitux

Erbitux has active ingredients of cetuximab. It is often used in oral cancer. (latest outcomes from Erbitux 8,142 users)

White Blood Cell Count Decreased

White blood cell count decreased has been reported by people with breathing difficulty, fever, agranulocytosis, weakness, diarrhea (latest reports from 34,572 White blood cell count decreased patients).

On Jul, 27, 2016

8,126 people reported to have side effects when taking Erbitux.
Among them, 201 people (2.47%) have White Blood Cell Count Decreased


Number of reports submitted per year:

Could Erbitux cause White blood cell count decreased?

Time on Erbitux when people have White Blood Cell Count Decreased *:

  • < 1 month: 78.76 %
  • 1 - 6 months: 21.24 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have White Blood Cell Count Decreased when taking Erbitux *:

  • female: 28.5 %
  • male: 71.5 %

Age of people who have White Blood Cell Count Decreased when taking Erbitux *:

  • 0-1: 0.0 %
  • 2-9: 1.05 %
  • 10-19: 0.52 %
  • 20-29: 0.0 %
  • 30-39: 0.52 %
  • 40-49: 3.66 %
  • 50-59: 21.47 %
  • 60+: 72.77 %

Top conditions involved for these people *:

  • Non-Small Cell Lung Cancer (28 people)
  • Head And Neck Cancer (18 people)
  • Rectal Cancer (15 people)
  • Oesophageal Adenocarcinoma (13 people)
  • Squamous Cell Carcinoma (12 people)

Top co-used drugs for these people *:

  • Cisplatin (82 people)
  • Taxol (63 people)
  • Carboplatin (52 people)
  • Radiation Therapy (43 people)
  • Decadron (24 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have White blood cell count decreased when taking Erbitux?

Browse all side effects of Erbitux

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with White blood cell count decreased

White blood cell count decreased

Could your condition cause White blood cell count decreased

White blood cell count decreased

You may be interested in these reviews

More reviews for: Erbitux, White blood cell count decreased


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.